These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28881819)

  • 41. Patient-Derived Xenograft Models of Breast Cancer and Their Application.
    Murayama T; Gotoh N
    Cells; 2019 Jun; 8(6):. PubMed ID: 31226846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers.
    Lan T; Xue X; Dunmall LC; Miao J; Wang Y
    Aging (Albany NY); 2021 Apr; 13(8):12273-12293. PubMed ID: 33903283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of Animal Models in Cancer Research: Recent Progress and Future Prospects.
    Li Z; Zheng W; Wang H; Cheng Y; Fang Y; Wu F; Sun G; Sun G; Lv C; Hui B
    Cancer Manag Res; 2021; 13():2455-2475. PubMed ID: 33758544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HI-511 overcomes melanoma drug resistance
    Chang X; Zhang T; Wang Q; Rathore MG; Reddy K; Chen H; Shin SH; Ma WY; Bode AM; Dong Z
    Theranostics; 2020; 10(21):9721-9740. PubMed ID: 32863956
    [No Abstract]   [Full Text] [Related]  

  • 45. Epigenetic Alterations in Oesophageal Cancer: Expression and Role of the Involved Enzymes.
    Lopes N; Correia MP; Henrique R; Jerónimo C
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model.
    Jin G; Yao K; Guo Z; Zhao Z; Liu K; Liu F; Chen H; Gorja DR; Reddy K; Bode AM; Dong Z; Dong Z
    Oncotarget; 2017 Aug; 8(32):53387-53404. PubMed ID: 28881819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer.
    Jin G; Yan M; Liu K; Yao K; Chen H; Zhang C; Yi Y; Reddy K; Gorja DR; Laster KV; Guo Z; Dong Z
    Oncogene; 2020 Oct; 39(43):6733-6746. PubMed ID: 32963350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. S39, a novel Aurora B kinase inhibitor, shows potent antineoplastic activity in human Hela cervical cancer cell line.
    Li J; Lang Q; Zhang H; Huang Q; Yu L
    Biotechnol Lett; 2013 Jun; 35(6):853-60. PubMed ID: 23443212
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A thienopyrimidine derivative induces growth inhibition and apoptosis in human cancer cell lines via inhibiting Aurora B kinase activity.
    Li J; Hu H; Lang Q; Zhang H; Huang Q; Wu Y; Yu L
    Eur J Med Chem; 2013 Jul; 65():151-7. PubMed ID: 23707920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting aurora kinases with danusertib (PHA-739358) inhibits growth of liver metastases from gastroenteropancreatic neuroendocrine tumors in an orthotopic xenograft model.
    Fraedrich K; Schrader J; Ittrich H; Keller G; Gontarewicz A; Matzat V; Kromminga A; Pace A; Moll J; Bläker M; Lohse AW; Hörsch D; Brümmendorf TH; Benten D
    Clin Cancer Res; 2012 Sep; 18(17):4621-32. PubMed ID: 22753592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas.
    Qi W; Liu X; Cooke LS; Persky DO; Miller TP; Squires M; Mahadevan D
    Int J Cancer; 2012 Jun; 130(12):2997-3005. PubMed ID: 21796626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current status of proteomics of esophageal carcinoma.
    Uemura N; Kondo T
    Expert Rev Proteomics; 2016 Nov; 13(11):1029-1040. PubMed ID: 27678273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis.
    Fan M; Lin Y; Pan J; Yan W; Dai L; Shen L; Chen K
    Thorac Cancer; 2016 Mar; 7(2):173-81. PubMed ID: 27042219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor.
    Durlacher CT; Li ZL; Chen XW; He ZX; Zhou SF
    Clin Exp Pharmacol Physiol; 2016 Jun; 43(6):585-601. PubMed ID: 26999067
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.